Abstract
Purpose: Our purpose was to evaluate the outcomes of gamete intrafallopian transfer (GIFT) therapy in patients with endometriosis.
Methods: One hundred eight GIFT cycles performed under the indication of endometriosis were compared to 156 GIFT cycles with indications of other disease entities. A maximum of seven oocytes was transferred into one or both fimbriate ends with prepared spermatozoa. Clinical pregnancy rates and outcomes were evaluated according to Mantel-Haenszel’s chi-square test. Multiple logistic regression analysis was performed to determine factors influencing the success on pregnancy in the total treatment cycles.
Results: The anthropological variables, such as age of patients, duration of infertility, and semen grading, were comparable in both groups. The responses to controlled ovarian hyperstimulation (COH) were progressively decreased while increasing the severity of endometriosis conditions such as nonendometriosis, mild-form endometriosis, and advanced-form endometriosis patients. However, there were no significant differences in the clinical pregnancy rates (40.4, 36.7, and 41.7%, respectively), multiple pregnancy rates (34.9, 27.3, and 45.0%, respectively), and early pregnancy loss rates (27.0, 18.2, and 30.0%, respectively). Multivariate statistics of pregnancy rates that adjusted the effects of patients’ age, tubal health, presence of active endometriosis and/or endometriomas, number of oocytes transferred, and quality of sperm exhibited no statistical significance between endometriosis and nonendometriosis groups.
Conclusions: Our data show that patients with records of endometriosis have both a decreased ovarian response to gonadotropin stimulation and a decreased number of retrieved oocytes. Since the number of oocytes needed for the GIFT procedure is limited, pregnancy results for patients in the study group were comparable with those for patients in the control group.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Speroff L, Glass RH, Kase NG: Endometriosis.In Clinical Gynecologic Endocrinology and Infertility, L. Speroff (ed). Baltimore, Williams and Wilkins, 1994, pp 853–871
Wessels PH, Trumpelmann MD, Cronje HS, Grobler S, Oosthuizen AP, Hamlett DK: Cost-effectiveness of gamete intrafallopian transfer in comparison with induction of ovulation with gonadotropins in the treatment of female infertility: A clinical trial. Fertil Steril 1992;57:163–167
Mills MS, Eddowes HA, Cahill DJ, Fahy UM, Abuzeid MIM, McDermott A, Hull MGR: A prospective controlled study of in-vitro fertilization, gamete intra-fallopian transfer and intrauterine insemination combined with superovulation. Hum Reprod 1992;7:490–494
Chillick CF, Acosta AA, Garcia JE, Perera S, Van Uem JFHM, Rosenwaks Z, Jones HW Jr: The role of in vitro fertilization in infertile patients with endometriosis. Fertil Steril 1985;44:56–61
Matson PL, Yovich JL: The treatment of infertility associated with endometriosis by in vitro fertilization. Fertil Steril 1986;46:432–434
Simon C, Gutierrez A, Vidal A, de los Santos MJ, Tarin JJ, Remohi J, Pellicer A: Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 1994;9:725–729
Geber S, Paraschos T, Atkinson G, Margara R, Winston RML: Results of IVF in patients with endometriosis: The severity of the disease does not affect outcome, or the incidence of miscarriage. Hum Reprod 1995;10:1507–1511
Dmowski WP, Friberg J, Rana N, Papierniak C, Michalowska J, El-Roeiy A: The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 1995;63:555–562
Wardle PG, Mitchell JD, McLaughlin EA, Ray BD, McDermott A, Hull MGR: Endometriosis and ovulatory disorder: Reduced fertilization in vitro compared with tubal and unexplained infertility. Lancet 1985;2:236–239
Schmidt CL: Endometriosis: A reappraisal of pathogenesis and treatment. Fertil Steril 1985;44:157–173
Nakamura K, Oosawa M, Kondou I, Inagaki S, Shibata H, Narita O, Suganuma N, Tomoda Y: Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis. J Assist Reprod Genet 1992;9:113–117
Dicker D, Feldberg D, Goldman JA, Ashkenazi J, Levy T: The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer. Fertil Steril 1992;57:597–600
Abramovici H, Dirnfeld M, Bornstein J, Lissak A, Gonen Y: Gamete intrafallopian transfer. An overview. J Reprod Med 1993;38:698–702
Asch RH: GIFT: Indications, results, problems, and perspectives. In Capitanio GL et al, editors: GIFT: From Basics to Clinics, Serono Symposia, Vol 63, EL Capitanioet al. (ed). New York, Raven Press, 1989
Guzick DS, Stovall DW, Yao YAS, Kubik CJ, Berga SL, Zeleznik AJ, Krasnow JS: Endometriosis impairs the efficacy of gamete intrafallopian transfer: Results of a case-control study. Fertil Steril 1994;62:1186–1191
American Fertility Society: Revised American Fertility Society classification of endometriosis. Fertil Steril 1985;43:351–354
Veeck LL: Atlas of the Human Oocyte and Early Conceptus. Baltimore, Williams & Wilkins, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chang, MY., Chiang, CH., Hsieh, TT. et al. The influence of endometriosis on the success of gamete intrafallopian transfer (GIFT). J Assist Reprod Genet 14, 76–82 (1997). https://doi.org/10.1007/BF02765774
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02765774